Results 11 to 20 of about 235,538 (306)

Advances in Platelet Counting [PDF]

Hematology, 2001
Accurate and reliable platelet counting is critical for the clinical management of platelet disorders, especially in thrombocytopenia. The platelet count is used to determine if the patient requires a platelet transfusion. As the prophylactic transfusion trigger is now set anywhere between 10-20 × 10(9)/L (depending upon the institution) it is ...
Samuel J. Machin, Carol Briggs, Paul Harrison   +2 more
openaire   +2 more sources

Association between platelets and in-hospital mortality in critically ill patients with tumours: a retrospective cohort study

BMJ Open, 2022
Objectives Platelet count is an independent predictor of mortality in patients with cancer. It remains unknown whether the platelet count is related to in-hospital mortality in severely ill patients with tumours.Design A retrospective study based on a ...
Yue Chen, Feng Jin, Yuanyuan Li, Yuxin Li, Chaofen Zhao, Zuoan Qin, Yaxue Tang, Lina Liu, Qianyong He, Jieqing Jiang, Shaoyuan Zhu, Xinyu Xu, Ding’an Zhou   +12 more
doaj   +1 more source

Platelet Counts during Pregnancy [PDF]

New England Journal of Medicine, 2018
(N Engl J Med. 2018;379:32–43) In the present study, the authors evaluated platelet counts in women (15 to 44 y of age) who delivered at the Oklahoma University Medical Center between 2011 and 2014. Their objectives were to (1) evaluate the potential severity of gestational thrombocytopenia (<150,000 platelets/mm3 at the time of delivery ...
Jennifer D. Peck, Deirdra R. Terrell, Jennifer McIntosh, James N. George, Jessica A. Reese, David R. Deschamps, Sara K. Vesely, Eric Knudtson   +7 more
openaire   +8 more sources

Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromsø Study. [PDF]

PLoS ONE, 2014
BACKGROUND: Elevated platelet count is associated with risk of venous thromboembolism in cancer patients initiating chemotherapy. It is not known whether this risk by platelet count is causal or merely reflects the malignant disease.
Hilde Jensvoll, Kristine Blix, Sigrid K Brækkan, John-Bjarne Hansen   +3 more
doaj   +1 more source

Evolution of platelet functions in cirrhotic patients undergoing liver transplantation: A prospective exploration over a month. [PDF]

PLoS ONE, 2018
This prospective observational study was designed to analyze platelet functions across time in 50 patients scheduled for liver transplantation (LT) secondary to decompensated cirrhosis or hepatocellular carcinoma.
Daniel Eyraud, Ludovic Suner, Axelle Dupont, Christilla Bachelot-Loza, David M Smadja, Dominique Helley, Sébastien Bertil, Ovidiu Gostian, Jean Szymezak, Yann Loncar, Louis Puybasset, Pascal Lebray, Corinne Vezinet, Jean-Christophe Vaillant, Benjamin Granger, Pascale Gaussem   +15 more
doaj   +1 more source

Improvement of platelet in thrombocytopenic HCV patients after treatment with direct-acting antiviral agents and its relation to outcome

Platelets, 2021
Little is known about evolution of platelet count after treatment with direct-acting antiviral agents (DAAs). The study aimed to evaluate the changes in platelet count after treatment with DAAs among thrombocytopenic patients with HCV-related advanced ...
Zeinab Soliman, Mohamed El Kassas, Aisha Elsharkawy, Mohamed Elbadry, Yasser Hamada, Ramy ElHusseiny, Saeed M. El-Nahaas, Rabab Fouad, Gamal Esmat, Shereen Abdel Alem   +9 more
doaj   +1 more source

Low Platelet Count Predicts Reduced Survival in Potentially Resectable Hepatocellular Carcinoma

Current Oncology, 2022
The prognostic role of platelet count in hepatocellular carcinoma (HCC) remains unclear, and in fact both thrombocytopenia and thrombocytosis are reported as predictors of unfavourable outcomes.
Christopher Schrecker, Oliver Waidmann, Hanan El Youzouri, Jörg Trojan, Andreas Anton Schnitzbauer, Wolf Otto Bechstein, Stefan Zeuzem, Christine Koch   +7 more
doaj   +1 more source

Modification of Platelet Count on the Association between Homocysteine and Blood Pressure: A Moderation Analysis in Chinese Hypertensive Patients

International Journal of Hypertension, 2020
Background. Platelet consumption followed by homocysteine-induced endothelial injury suggests a crosstalk between platelet activation and homocysteine on hypertension.
Jianan Zhang, Jing Li, Shi Chen, Linglin Gao, Xiaoluan Yan, Mingzhi Zhang, Jia Yu, Fenchun Wang, Hao Peng   +8 more
doaj   +1 more source

Pretreatment platelet count predicts survival outcome of patients with de novo non-M3 acute myeloid leukemia [PDF]

PeerJ, 2017
Background Pretreatment platelet count has been reported as a potential tool to predict survival outcome in several solid tumors. However, the predictive value of pretreatment platelet count remains obscure in de novo acute myeloid leukemia (AML ...
Qianying Zhang, Kanchun Dai, Laixi Bi, Songfu Jiang, Yixiang Han, Kang Yu, Shenghui Zhang   +6 more
doaj   +2 more sources

Lusutrombopag is effective and safe in patients with chronic liver disease and severe thrombocytopenia: a multicenter retrospective study

BMC Gastroenterology, 2020
Background Chronic liver disease (CLD) is often complicated by severe thrombocytopenia (platelet count  50,000/µL at baseline: the proportions of patients who did not require platelet transfusion were 84–96%, which might be overestimated.
Hiroaki Nomoto, Naoki Morimoto, Kouichi Miura, Shunji Watanabe, Yoshinari Takaoka, Hiroshi Maeda, Takahiro Sasaki, Yohei Koyashiki, Hidekazu Kurata, Norikatsu Numao, Norio Isoda, Hironori Yamamoto   +11 more
doaj   +1 more source